Neurocrine Biosciences
NBIX
#1462
Rank
A$18.78 B
Marketcap
$188.46
Share price
3.94%
Change (1 day)
-5.47%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): A$0.77 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are A$2.35 Billion. , an increase over its 2023 earnings that were of A$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 A$0.80 B64.57%
2023 A$0.48 B41.13%
2022 A$0.34 B73.74%
2021 A$0.19 B-8.82%
2020 A$0.21 B77.78%
2019 A$0.12 B49.83%
2018 A$81.77 M-142.57%
2017 -A$0.2 Billion-14.73%
2016 -A$0.23 Billion53.15%
2015 -A$0.15 Billion46.25%
2014 -A$0.11 Billion29.66%
2013 -A$77.58 Million-3530.8%
2012 A$2.26 M-95.73%
2011 A$52.96 M
2009 -A$74.47 Million-45.38%
2008 -A$0.14 Billion-58.87%
2007 -A$0.34 Billion87.3%
2006 -A$0.18 Billion351.97%
2005 -A$39.15 Million-52.09%
2004 -A$81.72 Million-10.98%
2003 -A$91.8 Million
2001 -A$68.53 Million
1999 -A$30.91 Million108.32%
1998 -A$14.84 Million
1996 A$4.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$30.01 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.43 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$50.51 Million-106.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.85 B 1,877.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.23 B 1,302.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.84 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$11.72 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$65.22 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA